133 related articles for article (PubMed ID: 17554028)
1. Virulence of a mouse-adapted Semliki Forest virus strain is associated with reduced susceptibility to interferon.
Deuber SA; Pavlovic J
J Gen Virol; 2007 Jul; 88(Pt 7):1952-1959. PubMed ID: 17554028
[TBL] [Abstract][Full Text] [Related]
2. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.
Fragkoudis R; Breakwell L; McKimmie C; Boyd A; Barry G; Kohl A; Merits A; Fazakerley JK
J Gen Virol; 2007 Dec; 88(Pt 12):3373-3384. PubMed ID: 18024907
[TBL] [Abstract][Full Text] [Related]
3. The avirulent A7 Strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain.
Atkins GJ
J Gen Virol; 1983 Jun; 64 (Pt 6)():1401-4. PubMed ID: 6854273
[TBL] [Abstract][Full Text] [Related]
4. Differences in Processing Determinants of Nonstructural Polyprotein and in the Sequence of Nonstructural Protein 3 Affect Neurovirulence of Semliki Forest Virus.
Saul S; Ferguson M; Cordonin C; Fragkoudis R; Ool M; Tamberg N; Sherwood K; Fazakerley JK; Merits A
J Virol; 2015 Nov; 89(21):11030-45. PubMed ID: 26311875
[TBL] [Abstract][Full Text] [Related]
5. Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.
Galbraith SE; Sheahan BJ; Atkins GJ
J Gen Virol; 2006 Apr; 87(Pt 4):937-947. PubMed ID: 16528043
[TBL] [Abstract][Full Text] [Related]
6. Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes.
Morris A; Tomkins PT; Maudsley DJ; Blackman M
J Gen Virol; 1987 Jan; 68 ( Pt 1)():99-106. PubMed ID: 3492589
[TBL] [Abstract][Full Text] [Related]
7. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
Smyth JM; Sheahan BJ; Atkins GJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
[TBL] [Abstract][Full Text] [Related]
8. Aurothiolates enhance the replication of Semliki Forest virus in the CNS and the exocrine pancreas.
Scallan MF; Fazakerley JK
J Neurovirol; 1999 Aug; 5(4):392-400. PubMed ID: 10463861
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of proinflammatory cytokines in mouse CNS correlates with replication rate of semliki forest virus but not with the strain of viral proteins.
Tuittila M; Nygårdas P; Hinkkanen A
Viral Immunol; 2004; 17(2):287-97. PubMed ID: 15279706
[TBL] [Abstract][Full Text] [Related]
10. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
[TBL] [Abstract][Full Text] [Related]
11. The Semliki Forest virus E2 gene as a virulence determinant.
Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE
J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
Kim KH; Rümenapf T; Strauss EG; Strauss JH
Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
[TBL] [Abstract][Full Text] [Related]
14. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.
Fazakerley JK; Pathak S; Scallan M; Amor S; Dyson H
Virology; 1993 Aug; 195(2):627-37. PubMed ID: 8393239
[TBL] [Abstract][Full Text] [Related]
15. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.
Barry G; Breakwell L; Fragkoudis R; Attarzadeh-Yazdi G; Rodriguez-Andres J; Kohl A; Fazakerley JK
J Gen Virol; 2009 Jun; 90(Pt 6):1382-1391. PubMed ID: 19264662
[TBL] [Abstract][Full Text] [Related]
16. An electron-microscopic study of avirulent and virulent Semliki forest virus in the brains of different ages of mice.
Pathak S; Webb HE
J Neurol Sci; 1978 Dec; 39(2-3):199-211. PubMed ID: 739267
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus.
Tarbatt CJ; Glasgow GM; Mooney DA; Sheahan BJ; Atkins GJ
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1551-7. PubMed ID: 9225028
[TBL] [Abstract][Full Text] [Related]
18. Semliki forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells.
Atkins GJ; Sheahan BJ
Infect Immun; 1982 Apr; 36(1):333-41. PubMed ID: 6176545
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.
Briolant S; Garin D; Scaramozzino N; Jouan A; Crance JM
Antiviral Res; 2004 Feb; 61(2):111-7. PubMed ID: 14670584
[TBL] [Abstract][Full Text] [Related]
20. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins.
Landis H; Simon-Jödicke A; Klöti A; Di Paolo C; Schnorr JJ; Schneider-Schaulies S; Hefti HP; Pavlovic J
J Virol; 1998 Feb; 72(2):1516-22. PubMed ID: 9445055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
